MONTREAL, Aug. 15, 2024 /CNW/ -- Abbott (NYSE: ABT) today announced that the AVEIR™ dual chamber (DR) leadless pacemaker system, the world's first dual chamber leadless pacemaker system that treats people with abnormal or slow heart rhythms,1 has been implanted for the first time at the Montreal Heart Institute, in Montreal, Quebec and Foothills Medical Centre in Calgary, Alberta.
Read more at newswire.caAbbott's AVEIR™ DR - World's First Dual Chamber Leadless Pacemaker System - Now Available in Canada
Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.